Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose spironolactone plus metformin versus either drug alone in adults with polycystic ovary syndrome
ChiCTR2000040178Phase 4Completed
- Sponsor
- Fifth Affiliated Hospital of Guangzhou Medical University
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin and spironolactone in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Fifth Affiliated Hospital of Guangzhou Medical University. Primary endpoints: luteinizing hormone, follicle-stimulating hormone and 4 more. Started Jan 2014; status: completed.
02
Drugs
metforminspironolactone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2000040178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040178.